Effects of sleep manipulation on markers of insulin sensitivity: A systematic review and meta-analysis of randomized controlled trials

Sondrup, Nina; Termannsen, Anne‐Ditte; Eriksen, J.; Hjorth, Mads Fiil; Færch, Kristine; Klingenberg, Lars; Quist, Jonas Salling

doi:10.1016/j.smrv.2022.101594

Cited by 40 publications

(29 citation statements)

References 75 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The quantity of sleep is known to be associated (in a U-shaped manner) with health outcomes (e.g., obesity and HbA 1c ), with both long (>8 h) and short (<6 h) sleep durations having negative impacts (97). By extending the sleep duration of short sleepers, it is possible to improve insulin sensitivity and reduce energy intake (117,125). However, "catch-up" weekend sleep alone is not enough to reverse the impact of insufficient sleep (126).…”

Section: Sleepmentioning

confidence: 99%

Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

et al. 2022

View full text Add to dashboard Cite

The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the previous consensus statements on the management of hyperglycemia in type 2 diabetes in adults, published since 2006 and last updated in 2019. The target audience is the full spectrum of the professional health care team providing diabetes care in the U.S. and Europe. A systematic examination of publications since 2018 informed new recommendations. These include additional focus on social determinants of health, the health care system, and physical activity behaviors, including sleep. There is a greater emphasis on weight management as part of the holistic approach to diabetes management. The results of cardiovascular and kidney outcomes trials involving sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists, including assessment of subgroups, inform broader recommendations for cardiorenal protection in people with diabetes at high risk of cardiorenal disease. After a summary listing of consensus recommendations, practical tips for implementation are provided.

show abstract

Section: Sleepmentioning

confidence: 99%

Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Physical activity behaviours significantly impact cardiometabolic health in type 2 diabetes (Fig. 2 ) [ 96 – 117 ]. Regular aerobic exercise (i.e.…”

Section: Therapeutic Options: Lifestyle and Healthy Behaviour Weight ...mentioning

confidence: 99%

“…obesity and HbA 1c ), with both long (>8 h) and short (<6 h) sleep durations having negative impacts [ 97 ]. By extending the sleep duration of short sleepers, it is possible to improve insulin sensitivity and reduce energy intake [ 117 , 125 ]. However, ’catch-up’ weekend sleep alone is not enough to reverse the impact of insufficient sleep [ 126 ].…”

Section: Therapeutic Options: Lifestyle and Healthy Behaviour Weight ...mentioning

confidence: 99%

Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

et al. 2022

View full text Add to dashboard Cite

The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the previous consensus statements on the management of hyperglycaemia in type 2 diabetes in adults, published since 2006 and last updated in 2019. The target audience is the full spectrum of the professional healthcare team providing diabetes care in the USA and Europe. A systematic examination of publications since 2018 informed new recommendations. These include additional focus on social determinants of health, the healthcare system and physical activity behaviours including sleep. There is a greater emphasis on weight management as part of the holistic approach to diabetes management. The results of cardiovascular and kidney outcomes trials involving sodium–glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists, including assessment of subgroups, inform broader recommendations for cardiorenal protection in people with diabetes at high risk of cardiorenal disease. After a summary listing of consensus recommendations, practical tips for implementation are provided. Graphical abstract Supplementary Information The online version of this article (10.1007/s00125-022-05787-2) contains peer-reviewed but unedited supplementary material.

show abstract

“…Underlying inflammation-related diseases may need to be addressed, such as metabolic syndrome, sleep apnea, and any type of joint or muscle pain [ 77 , 78 ]. Even hormonal fluxes related to estrogen, cortisol, and insulin are essential to assess for imbalance and correct accordingly [ 79 , 80 , 81 ]. Moreover, there may be an association between environmental toxins such as heavy metals (e.g., arsenic) and sleep disturbance [ 82 , 83 ].…”

Section: Clinical Usesmentioning

confidence: 99%

Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements

Minich

Henning²,

Darley

et al. 2022

Nutrients

View full text Add to dashboard Cite

Melatonin has become a popular dietary supplement, most known as a chronobiotic, and for establishing healthy sleep. Research over the last decade into cancer, Alzheimer’s disease, multiple sclerosis, fertility, PCOS, and many other conditions, combined with the COVID-19 pandemic, has led to greater awareness of melatonin because of its ability to act as a potent antioxidant, immune-active agent, and mitochondrial regulator. There are distinct similarities between melatonin and vitamin D in the depth and breadth of their impact on health. Both act as hormones, affect multiple systems through their immune-modulating, anti-inflammatory functions, are found in the skin, and are responsive to sunlight and darkness. In fact, there may be similarities between the widespread concern about vitamin D deficiency as a “sunlight deficiency” and reduced melatonin secretion as a result of “darkness deficiency” from overexposure to artificial blue light. The trend toward greater use of melatonin supplements has resulted in concern about its safety, especially higher doses, long-term use, and application in certain populations (e.g., children). This review aims to evaluate the recent data on melatonin’s mechanisms, its clinical uses beyond sleep, safety concerns, and a thorough summary of therapeutic considerations concerning dietary supplementation, including the different formats available (animal, synthetic, and phytomelatonin), dosing, timing, contraindications, and nutrient combinations.

show abstract

Effects of sleep manipulation on markers of insulin sensitivity: A systematic review and meta-analysis of randomized controlled trials

Cited by 40 publications

References 75 publications

Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements

Contact Info

Product

Resources

About